Wegovy vs Mounjaro: Complete Treatment Comparison
What Does Wegovy Do Differently from Mounjaro?
Understanding what Wegovy does compared to Mounjaro begins with their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural satiety hormones to reduce appetite and promote feelings of fullness after smaller meals. Mounjaro, containing tirzepatide, targets both GLP-1 and GIP receptors, offering a dual-hormone approach to weight management. Both treatments are designed to work alongside lifestyle modifications, but their different pathways may suit different individuals.
The dosing schedules also differ significantly between these treatments. Wegovy follows a structured 5-dose escalation from 0.25mg to the 2.4mg maintenance dose over 16 weeks, while Mounjaro offers 6 dose levels from 2.5mg up to 15mg. This means what Wegovy does in terms of dose progression is more gradual, potentially offering better tolerability for some patients. EverydayMeds stocks both options, allowing your prescriber to recommend the most appropriate treatment based on your individual assessment.
Wegovy Pricing and Value Compared to Mounjaro
When considering what Wegovy does for your budget, our transparent pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout to access these prices, while returning customers use DOSE25. Our Getting Started bundles, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, provide convenient multi-dose packages for seamless treatment progression.
Mounjaro pricing follows a different structure reflecting its distinct dosing requirements, with all doses available through our comprehensive assessment process. The key advantage of choosing EverydayMeds is access to both treatments through one trusted pharmacy (GPhC #9012878), eliminating the need to switch providers if your prescriber recommends changing treatments. Our Bundle options, including the Ultimate Stability Trio providing three months of maintenance supply, offer convenient long-term treatment planning without the complexity of multiple separate orders.
What Does Wegovy Do in Clinical Trials?
Clinical evidence demonstrates what Wegovy does in controlled studies, with the landmark STEP trials showing significant results. In the STEP 1 trial, participants taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 2 study focusing on patients with type 2 diabetes showed approximately 9.6% average weight loss, while STEP 3 combined with intensive behavioural therapy achieved around 16% average weight reduction.
Long-term data from STEP 5 maintained approximately clinically studied weight loss at two years, while the recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events. These studies provide insight into what Wegovy does when used as prescribed, though individual results may vary significantly. Both Wegovy and Mounjaro have shown substantial efficacy in their respective trials, though direct comparisons are challenging due to different study designs and participant populations.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding what Wegovy does requires grasping its GLP-1 receptor agonist mechanism. Semaglutide mimics the action of glucagon-like peptide-1, a natural hormone released in your intestines after eating that signals fullness to your brain. This mechanism reduces appetite, promotes satiety after smaller meals, and may help reduce food cravings by working on brain appetite centres. The once-weekly injection maintains consistent hormone levels, providing sustained appetite regulation throughout the week. Unlike rapid-acting appetite suppressants, Wegovy's mechanism works gradually to retrain your relationship with food, supporting long-term weight management when combined with lifestyle changes.
Ordering Process: Assessment to Delivery
Accessing what Wegovy does for your weight management journey starts with our streamlined 3-minute online clinical assessment. This comprehensive questionnaire covers your medical history, current medications, and weight management goals to ensure Wegovy is appropriate for your circumstances. Your assessment is reviewed by our qualified prescribers, with standard review taking 3 working days or express 24-hour processing available. Once approved, your Wegovy prescription is dispensed from our GPhC-registered pharmacy and dispatched via next-day cold-chain delivery to maintain the medication's integrity. Our temperature-controlled packaging ensures your Wegovy arrives in perfect condition, ready for refrigerated storage until first use.
Storage and Practical Considerations
What Wegovy does in terms of practical convenience includes superior storage flexibility compared to Mounjaro. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day limit, making travel and daily use more convenient. The FlexTouch pen design provides precise dosing with clear dose windows and simple injection procedures. Before first use, store Wegovy in your refrigerator at 2-8°C, and follow the mandatory dose escalation schedule to minimize potential side effects. Each pen contains exactly one week's treatment, with dose progression occurring every four weeks under prescriber guidance.
What Does Wegovy Do for Long-term Weight Management?
The sustained action of what Wegovy does extends beyond immediate appetite suppression to support long-term weight management strategies. Clinical data shows that Wegovy's effects are maintained with continued use, but weight regain occurs if treatment is discontinued, with patients typically regaining approximately two-thirds of weight lost within one year of stopping. This highlights that weight management is a long-term commitment requiring ongoing lifestyle modifications alongside medication. The 7.2mg higher-dose formulation approved by MHRA on 6 January 2026 may offer additional options for patients requiring enhanced treatment, though this remains under review for future availability.
Comparing what Wegovy does versus Mounjaro reveals that both treatments offer valuable weight management support through different mechanisms. Your individual response, medical history, lifestyle factors, and prescriber recommendation will determine which treatment is most appropriate. EverydayMeds' unique position as a provider of both treatments ensures continuity of care if treatment changes are required, with comprehensive support throughout your weight management journey.
Expert Guidance and Treatment Selection
What Wegovy does for your specific circumstances depends on professional medical assessment and ongoing monitoring. Our qualified prescribers evaluate your complete medical profile, including BMI, comorbidities, current medications, and previous weight management attempts to recommend the most suitable treatment. Both Wegovy and Mounjaro are prescription-only medicines requiring specialist oversight, with regular review ensuring optimal dosing and monitoring for potential side effects. The choice between treatments isn't about which is universally "better," but which aligns with your individual medical needs and lifestyle requirements. Use code FIRST40 for new customers or DOSE25 for returning customers when ordering through https://everydaymeds.co.uk/collections/weight-loss, and our clinical team will guide you through the complete assessment and treatment selection process with expert care and attention.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
